−£192k
vs Jan 2025Active12329134Private limited companyLondon
SENARI PHARMA LTD
Significant control: Sanjeeva Dissanayake (50–75%), Zarni Win (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Senari Pharma Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
SENARI PHARMA LTD is an active private limited company (company number 12329134) incorporated on 22 November 2019, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 January 2026, showing net assets of −£192k and cash of £14k, with 1 employee on average. Net assets fell 9% on the prior period (−£177k). Across the last 3 periods on record the net-asset trend is falling.
Peer position · net assets
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Dr Sanjeeva Dissanayake
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
- Mr Zarni Win
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 22 November 20196 yrs ago
- Next accounts due
- 31 October 2027in 373 days
- Confirmation statement due
- 6 December 2026in 44 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£14k
+642%vs Jan 2025Not reported
1
No changevs Jan 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2026 | −£192k | £14k | £930 | £207k | — | — | 1 |
| 31 January 2025 | −£177k | £1,878 | £27k | £206k | — | — | 1 |
| 31 January 2024 | −£120k | £385 | £27k | £147k | — | — | 1 |
Current ratio0.07Current assets ÷ creditors within one year
Cash per employee£14kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-192,497 at 31 January 2026
- Current assets below creditors within one yearCurrent ratio 0.07
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 22 November 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 373 days
- Confirmation statement duein 44 days
- Accounts period endNet liabilities £192k · small accounts
- Accounts period endNet liabilities £177k · small accounts
- Accounts period endNet liabilities £120k · small accounts
- Incorporated
08
Similar companies in London
- OXREGEN BIO LIMITEDLondon · inc. Nov 2019
- KARBONITE LTDLondon · inc. Nov 2019
- GROUND TRUTH LABS LTDLondon · inc. Nov 2019
- DAWN THERAPEUTICS LIMITEDLondon · inc. Nov 2019
- RELATION THERAPEUTICS LIMITEDLondon · inc. Nov 2019
- GREY MEDICAL LTDLondon · inc. Nov 2019
All companies incorporated on 22 November 2019 · in Nov 2019.
09
Reminders for SENARI PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.